Now Live: Cboe Europe real-time data for all major European stocks.
closes in 2h 58m
Post-market

STOCKS is currently open for post-market.
Post market session closes in 2 hours 58 minutes

17:02
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EDT, UTC-04:00).
3.25 USD
0.02
0.61%
Last update Mar 31, 3:59 PM EDT
Post-market
Day range
3.22300
3.37000
Previous close
3.27000
Open
3.30000
Access this stock data via API
Subscribe
Tharimmune Inc.
3.25
0.02
0.61%

Overview

Access /time_series data via our API — starting from the Basic plan and above.

Description

Tharimmune Inc. is a biotechnology company focused on the development and commercialization of innovative immunotherapies. The company's core purpose is to address unmet medical needs by leveraging cutting-edge research in immunology to create therapies that harness the body's immune system to fight diseases, particularly in the field of oncology and autoimmune disorders. Tharimmune Inc. applies advanced technologies such as monoclonal antibodies and novel biologics in its development pipeline. By operating at the intersection of science and healthcare, the company contributes significantly to the biopharmaceutical industry, driving forward cures and treatments that can transform patient outcomes. As a player in the biotechnology sector, Tharimmune is known for its rigorous research approach and strategic partnerships, which are pivotal in advancing both clinical trials and market approval of its products. The company's commitment to innovation positions it as a vital contributor to the broader healthcare landscape, with potential impacts on patient health and treatment paradigms worldwide. Tharimmune's advancements in immunotherapies underscore its pivotal role in the dynamic and evolving pharmaceuticals market.

About

CEO
Mr. Mark Wendland
Employees
2
Address
34 Shrewsbury Avenue
Suite 1C
Red Bank, 07701, NJ
United States
Phone
732 889 3111
Instrument type
Common stock
Sector
Healthcare
Industry
Biotechnology
Country
United States
MIC code
XNCM
Access /profile data via our API — starting from the Grow plan (individual) and the Venture plan (business) and above.

Latest press releases

Feb 17, 2026
Tharimmune, Inc. Announces Corporate Rebrand to Canton Strategic Holdings, Inc., Marking Milestone in Canton Network Digital Asset Treasury Strategy

New NASDAQ Ticker Symbol "CNTN" to Begin Trading February 18, 2026

Company Positioned to Support Institutional Adoption of First Privacy-Enabled Public Blockchain Processing $9 Trillion in Monthly Transaction Volume

NEW YORK, Feb. 17, 2026 /PRNewswire/ -- Tharimmune, Inc. (NASDAQ: THAR) (the "Company") the first publicly traded company to leverage Canton Coin to support the Canton Network's ability to digitize traditional financial markets, today announced the launch of a corporate rebrand in alignment with its digital asset treasury strategy. Effective Wednesday, February 18, 2026, the Company will change its name to Canton Strategic Holdings, Inc. In connection with the name change, the common stock of the Company will begin trading on NASDAQ under the ticker symbol "CNTN" prior to market open on February 18, 2026.

Established in November 2025 through a $545 million private placement, the Company executes a differentiated digital asset treasury strategy that seeks to drive value through initiatives including Canton Coin acquisition, operation of a Super Validator, and continued investment in applications that accelerate institutional utility and adoption of the Canton Network across capital markets. Canton Strategic Holdings remains the first and only publicly traded company supported by the Canton Foundation.

"Since launching our digital asset treasury strategy, we have continued to execute against a clear mandate to support institutional adoption of the Canton Network," said Mark Wendland, Chairman and CEO of the Company. "Our approval to operate a Super Validator on the Network, the expansion of institutional leadership on our Board of Directors, and our commitment to develop quarterly ecosystem reporting demonstrates our ability to strengthen the Canton ecosystem while delivering sustained value for shareholders."

Significant recent milestones for the Company include:

  • Securing approval as a Super Validator, aligned with a commitment to provide ecosystem reports on a quarterly basis.
  • Deepening institutional expertise on the Board of Directors, including recent appointments of Former CFTC Commissioner Jill Sommers and DRW Chief of Staff William Wiley.
  • Closing of a $55 million underwritten registered offering to provide the Company with additional growth capital for the continued expansion and development of its Canton-centric digital asset treasury strategy.

"From DTCC securing SEC consent for a pilot to tokenize U.S. Treasury securities, to global enterprises implementing onchain payroll, the utility of the Canton Network and its configurable privacy has quickly become the foundation for onchain financial rails," continued Mr. Wendland. "We are well-positioned to accelerate this modernization through our support of the Canton Network and strategic work to strengthen the ecosystem while driving value for shareholders."

No action is required from stockholders in connection with the change of the Company's corporate name or ticker symbol. 

About the Company

The Company (NASDAQ: THAR), is the first publicly traded company to leverage Canton Coin and support the Canton Network to advance institutional blockchain adoption and the digitization of financial markets. In addition to driving value through activities on the Canton Network, the Company also operates clinical-stage biotech research and development. For more information, visit: www.cantonstrategic.com 

Cautionary Note Regarding Forward-Looking Statements

This press release contains statements that constitute "forward-looking statements" within the meaning of U.S. federal securities laws. Forward-looking statements are statements other than historical facts and include, without limitation, those regarding management expectations, strategy execution, market conditions, and the Company's involvement with the Canton Network. These statements are based on current expectations and involve risks and uncertainties that may cause actual results to differ materially. Further information regarding factors that may affect the Company's prospects is included in its annual and quarterly reports filed with the U.S. Securities and Exchange Commission, available at www.sec.gov. The Company undertakes no obligation to update these statements except as required by law.

Canton is a registered trademark of Digital Asset (Switzerland) GmbH. Digital Asset is not affiliated with, and has not sponsored or endorsed, the operations of Canton Strategic Holdings, Inc.

Contacts

Media:

Gasthalter & Co.

(212) 257-4170

canton@gasthalter.com

Investors:

ir@cantonstrategic.com

X: @CantonStrategic

LinkedIn: Linkedin.com/CantonStrategicHoldings

Website: www.cantonstrategic.com 

Cision View original content:https://www.prnewswire.com/news-releases/tharimmune-inc-announces-corporate-rebrand-to-canton-strategic-holdings-inc-marking-milestone-in-canton-network-digital-asset-treasury-strategy-302689437.html

SOURCE Tharimmune, Inc.

Feb 6, 2026
Tharimmune, Inc. Appoints Mark Wendland Chairman of the Board and Names Angela Radkowski Chief Operating Officer

Leadership Expansion Supports Execution of Canton Network Infrastructure Strategy

Former DRW and Citadel Leader Joins as COO to Drive Institutional Platform Expansion

NEW YORK, Feb. 6, 2026 /PRNewswire/ -- Tharimmune, Inc. (NASDAQ: THAR) ("Tharimmune" or the "Company"), the first publicly traded company to leverage Canton Coin ("CC") to support the Canton Network's ability to digitize traditional financial markets, today announced that its Board of Directors (the "Board") has elected Mark Wendland, Chief Executive Officer, as Chairman of the Board and approved the appointment of Angela Radkowski as Chief Operating Officer, effective February 5, 2026. Mr. Wendland succeeds Vincent LoPriore, who will transition to a member of the Board after serving as Chairman since May 9, 2025.

In her role as COO, Ms. Radkowski will oversee operational control functions and enterprise processes, including the implementation of Tharimmune's Canton Network quarterly research initiative and Super Validator activation.

"I am honored to assume the role of Chairman as we continue executing on our Canton Network-aligned digital asset strategy to help modernize financial market infrastructure," said Mark Wendland. "The Board, under the dedicated leadership of Vincent LoPriore, has demonstrated an unwavering commitment to building a governance and operating structure capable of supporting our digital asset treasury strategy, and Angela's appointment adds critical leadership at a pivotal moment. Her experience scaling complex financial systems will be instrumental as we advance institutional adoption of Canton Network and drive value for shareholders."

Prior to her appointment, Ms. Radkowski served as Operations Strategy Lead and Chief of Staff to the Chief Operating Officer at DRW Holdings LLC, advising senior leadership, coordinating cross-functional communication, and managing high-priority, enterprise-level initiatives. Ms. Radkowski previously held positions within Citadel LLC's Treasury and Engineering organizations, where she was responsible for coordinating enterprise deliverables involving optimization, data engineering, and technology upgrades.

Ms. Radkowski added, "The Canton Network introduces a new model for institutional finance — one that addresses the limitations of legacy infrastructure while enabling secure, scalable blockchain adoption. I am excited to join Tharimmune and help build the operational foundation required to support this transformation."

Tharimmune established its differentiated digital asset treasury strategy in November 2025. In addition to driving value through CC acquisition and operating as a Super Validator, Tharimmune intends to invest in applications built on the Canton Network that accelerate institutional utility and adoption across capital markets. Tharimmune is the first and only publicly traded company supported by the Canton Foundation.

About Tharimmune

Tharimmune, Inc. (NASDAQ: THAR) is the first publicly traded company to leverage Canton Coin and support the Canton Network to advance institutional blockchain adoption and the digitization of financial markets. In addition to driving value through activities on the Canton Network, Tharimmune also operates clinical-stage biotech research and development. For more information, visit: www.tharimmune.com.

Cautionary Note Regarding Forward-Looking Statements

This press release contains statements that constitute "forward-looking statements" within the meaning of U.S. federal securities laws. Forward-looking statements are statements other than historical facts and include, without limitation, those regarding management expectations, strategy execution, market conditions, and the Company's involvement with the Canton Network. These statements are based on current expectations and involve risks and uncertainties that may cause actual results to differ materially. Further information regarding factors that may affect the Company's prospects is included in its annual and quarterly reports filed with the U.S. Securities and Exchange Commission, available at www.sec.gov. The Company undertakes no obligation to update these statements except as required by law.

Contacts

Media:

Gasthalter & Co.

(212) 257-4170

canton@gasthalter.com

Investors:

ir@tharimmune.com

X: @TharimmuneInc

LinkedIn: https://www.linkedin.com/company/tharimmune-inc/

Website: https://tharimmune.com/

Cision View original content:https://www.prnewswire.com/news-releases/tharimmune-inc-appoints-mark-wendland-chairman-of-the-board-and-names-angela-radkowski-chief-operating-officer-302681307.html

SOURCE Tharimmune, Inc.

Access /press_releases data via our API — starting from the Basic plan and above.
Post-market

Exchange is currently open for post-market.
Post market session closes in 2 hours 58 minutes

17:02
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EDT, UTC-04:00).